학술논문

Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study
Document Type
Article
Source
Leukemia; August 2018, Vol. 32 Issue: 8 p1799-1803, 5p
Subject
Language
ISSN
08876924; 14765551